Background: While spondyloarthritis (SpA) is intensively studied in the Western world, data are scarce in sub-Saharan Africa. Objectives: To determine the spectrum of SpA in outpatients with rheumatological complaints attending two rheumatology practices in Kinshasa, Democratic Republic of Congo. Methods: A descriptive cross-sectional study over six months (December 1st, 2012 till May 31th, 2013 in consecutive patients attending the two rheumatology practices of Kinshasa; diagnosis was based on Amor or the ESSG criteria, and a clinical evaluation by a rheumatologist. Sacroiliac joint radiographic lesions were scored with the modified New York criteria. BASDAI and BASFI were evaluated in axial SpA. Results: One hundred five patients (10.7%) were diagnosed among 984 rheumatologic outpatients with a sex ratio (male to female) of 1.4. The average age at the onset of the disease was 41.3±12.4 years. Non-radiographical axial spondyloarthritis was the most frequent subtype (4.98%) followed by reactive arthritis (4.27%). Other subtypes were: ankylosing spondylitis (1.02%), psoriatic arthritis (0.1%), SAPHO syndrome (0.1%) and IBD associated arthritis (0.1%). Mean BASDAI and BASFI in axial SpA were 42.7/100 and 46.4/100 respectively. Peripheral enthesitis was found in 43% of SpA patients and uveitis (10.4%) was the most frequent extra-articular manifestation. We did not detect any family history. Median erythrocyte sedimentation rate and C reactive protein were 37 (range: 7-110) mm/h and 22 (range: 4-48) mg/l respectively. Background: Inflammatory spondyloarthropathies (SpAs), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) are associated with cardiovascular (CV) disorders. In both diseases cytokines of IL-17/IL-23 axis are thought to play a pathogenic role. PsA, but not AS, is usually preceded by psoriasis, suggesting contribution of skin inflammation-related cytokines to disease manifestation and CV risk. Objectives: To search in AS and PsA patients for the association between CV risk and serum concentrations of select cytokines, i.e. of IL-17/IL-23 axis, IL-18 and osteoprotegerin (OPG) related to skin inflammation and/or cardiovascular disease (CVD) pathogenesis, respectively. Methods: Twenty patients with AS (15M/5F) and 18 patients with PsA (10M/8F) of similar age (mean±SD, 42±7 vs 46±10 years) and disease duration (6.5±10 vs 6.1±7 years) were evaluated. A group of 38 sex and age-matched healthy volunteers was used as a control. Routine laboratory tests, i.a. measurement of serum C-reactive protein (CRP) concentrations were performed. Clinical data, including evaluation of disease activity by ASDAS CRP and BASDAI indices, calculation of SCORE (Systemic Coronary Risk Evaluation) index and atherogenic index (AI=total cholesterol/HDL) were collected. Serum concentrations of IL-17AF, IL-21, IL-23, IL-27, IL-18 and OPG were measured by specific commercially available enzyme-linked immunosorbent assays (ELISA) and were expressed in pg/ml. The Mann-Whitney U-test was applied for intergroup comparison, and correlation was assessed using a Spearman's Rank two-tailed test (R value is shown). Results: Compared with control, total group of SpAs patients was characterized by significantly elevated serum concentrations of OPG (1757±852 vs 1062±406 pg/ml), IL-18 (273±235 vs 164±195 pg/ml) and IL-21 (68±127 vs 20±49 pg/ml). Interestingly, while up-regulation of OPG (1517±387) and IL-18 (324±291) was attributed to PsA, IL-21 increase (90.6±158) was found in AS group. Nevertheless, there was no significant difference between patients' groups in the tested cytokines concentrations. 2 ). AS patients had significantly lower levels of HDL and TC and a higher level of CRP and atherogenic index (TC/HDL, ApoB/ApoA). AS patients had higher CV mortality than controls (1.1±1.8 vs 0,51±1.13%, p=0.01). The frequency of high cardiovascular risk was higher in AS patients (5 vs 2, p=0.4). The correlation between SCORE's risk and biological markers were positive with TC, LDL, Lp (a), TC/HDL ratio and LDL/HDL ratio. Conclusions: AS patients are at a greater cardiovascular risk due to a higher CRP rate, atherogenic index and 10-year risk SCOREs of CV mortality. So, the dyslipidaemia and inflammation could be the aetiology of cardiovascular risk. 
